IORT with electrons as boost strategy during breast conserving therapy in limited stage breast cancer: long term results of an ISIORT pooled analysis

Articolo

Data di Pubblicazione:

2013

Citazione:

Fastner, G., Sedlmayer, F., Merz, F., Deutschmann, H., Reitsamer, R., Menzel, C., Stierle, C., Farmini, A., Fischer, T., Ciabattoni, A., Mirri, M. A., Hager, E., Reinartz, G., Lemanski, C., Orecchia, R., Valentini, V., IORT with electrons as boost strategy during breast conserving therapy in limited stage breast cancer: long term results of an ISIORT pooled analysis, <>, 2013; 108 (2): 279-286. [doi:10.1016/j.radonc.2013.05.031] [http://hdl.handle.net/10807/52017]

Abstract:

Linac-based intraoperative radiotherapy with electrons (IOERT) was implemented to prevent local recurrences after breast conserving therapy (BCT) and was delivered as an intraoperative boost to the tumor bed prior to whole breast radiotherapy (WBI). A collaborative analysis has been performed by European ISIORT member institutions for long term evaluation of this strategy.

Tipologia CRIS:

Articolo in rivista, Nota a sentenza

Keywords:

Boost; Breast cancer; Electrons; IOERT; Intraoperative radiotherapy

Elenco autori: